Table 1.
Variable | Mean ± SD | P value | |
---|---|---|---|
Patients with complete clearance/marked improvement† (n = 28) | Patients with mild/moderate improvement† (n = 4) | ||
Age in years | 35.2 ± 7.2 | 39.8 ± 2.1 | 0.224 |
Illness duration in months | 11.5 ± 7.1 | 21.0 ± 11.5 | 0.032 |
Itching score‡ | 5.9 ± 1.2 | 8.0 ± 1.2 | 0.001 |
Discomfort score‡ | 5.3 ± 1.0 | 8.3 ± 1.0 | <0.001 |
SD = standard deviation.
Daily Xamiol® gel (Leo Laboratories Ltd., Ballerup, Denmark).
Assessed by an attending dermatologist using the Physician Global Assessment Scale as either 0 (almost clear), 1 (mild), 2 (moderate), 3 (severe) or 4 (very severe).8
Self-reported by patients using a visual analogue scale on a scale of 0 (no symptoms) to 10 (most severe).